Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis-Reference-Cited by-同舟云学术

Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis

Published:2019-05-02 Issue:8 Volume:66 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Boscolo Elisa¹²^ORCID,Pastura Patricia²³,Glaser Kathryn²,Goines Jillian¹²,Hammill Adrienne M.²⁴,Adams Denise M.⁵⁶⁷^ORCID,Dickie Peter²,Hsi Dickie Belinda⁶⁷⁸,Cras Timothy D.²³^ORCID

Affiliation:

1. Division of Experimental Hematology and Cancer BiologyUniversity of Cincinnati College of Medicine Cincinnati Ohio

2. Department of PediatricsUniversity of Cincinnati College of Medicine Cincinnati Ohio

3. Division of Pulmonary BiologyCincinnati Children's Hospital Cincinnati Ohio

4. Hemangioma and Vascular Anomalies Center and Division of HematologyCincinnati Children's Hospital Cincinnati Ohio

5. Vascular Anomalies Center Boston Massachusetts

6. Boston Children's Hospital Boston Massachusetts

7. Harvard Medical School Boston Massachusetts

8. Colorectal and Pelvic Malformation Center Boston Massachusetts

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27790

Reference25 articles.

1. Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic Anomaly

2. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies

3. Kaposiform lymphangiomatosis: Unifying features of a heterogeneous disorder

4. Successful treatment of kaposiform lymphangiomatosis with sirolimus

5. Sirolimus in the treatment of vascular anomalies;Triana P;Eur J Pediatr Surg,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapies for vascular malformations;Frontiers in Medicine;2024-09-03

2. Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies;Pediatric Blood & Cancer;2024-05-16

3. Lymphatic endothelial cell-specific NRAS p.Q61R mutant embryos show abnormal lymphatic vessel morphogenesis;Human Molecular Genetics;2024-05-13

4. A high-throughput zebrafish screen identifies novel candidate treatments for Kaposiform Lymphangiomatosis (KLA);2024-03-25

5. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review;European Journal of Medical Research;2024-02-15